Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Medtronic intends to spin off its respirator and patient monitoring businesses into a separate enterprise, which according to the medical device maker, will “enable greater investment focus in the areas of highest strategic priority.” (Fierce Biotech)

Sharon Inouye and Jason Resendez examine how including family caregivers in clinical trials may improve results and the clinical landscape. (STAT)

A Canadian company, Halucenex, is conducting a clinical trial to study psilocybin—the chemical in hallucinogenic mushrooms—as treatment for post-traumatic stress disorder. (CBC News)

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!

‍

‍

Our Culture

“Technology and process improvements will continue to decrease our timelines on creating specifications by 50 percent or more, this year. The more we continue to improve the faster we will be.”

‍      –Jamie, Trial Delivery
‍
‍

‍‍

‍

‍

About Judi

Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.